Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.12B P/E 6.58 EPS this Y - Ern Qtrly Grth 15.80%
Income 265.19M Forward P/E 10.00 EPS next Y -20.30% 50D Avg Chg -1.00%
Sales 365.49M PEG 0.42 EPS past 5Y 74.15% 200D Avg Chg 13.00%
Dividend N/A Price/Book 3.39 EPS next 5Y 19.34% 52W High Chg -8.00%
Recommedations 4.00 Quick Ratio 27.47 Shares Outstanding 69.49M 52W Low Chg 75.00%
Insider Own 0.79% ROA 25.99% Shares Float 56.82M Beta 0.48
Inst Own 103.21% ROE 76.06% Shares Shorted/Prior 9.16M/9.89M Price 16.10
Gross Margin 99.64% Profit Margin 72.56% Avg. Volume 789,695 Target Price -
Oper. Margin 94.92% Earnings Date Oct 27 Volume 467,920 Change 1.19%
Innoviva, Inc. News
10/27/21 Innoviva Reports Third Quarter 2021 Financial Results
10/12/21 Innoviva (NASDAQ:INVA) shareholders have earned a 11% CAGR over the last five years
10/08/21 Innoviva Stock In Buy Range; Joins Ranks Of Top-Performing Stocks With Strength Ratings Over 90
03:05 PM Innoviva Reports Second Quarter 2021 Financial Results
07/16/21 Have Insiders Been Buying Innoviva, Inc. (NASDAQ:INVA) Shares?
06/10/21 Are Institutions Heavily Invested In Innoviva, Inc.'s (NASDAQ:INVA) Shares?
05/20/21 Innoviva Announces Strategic Repurchase of GSK’s Equity Stake
05/05/21 Entasis Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
05/05/21 A Look At Innoviva's (NASDAQ:INVA) Share Price Returns
05/03/21 Entasis Therapeutics Completes Initial Closing of $20M Private Placement with Innoviva
03:05 PM Innoviva Reports First Quarter 2021 Financial Results
03/17/21 Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $20 Million Private Placement with Innoviva
03/08/21 Moving Average Crossover Alert: Innoviva
03/05/21 Innoviva, Inc.'s (NASDAQ:INVA) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
02/03/21 Innoviva: Q4 Earnings Insights
02/03/21 Innoviva Reports Fourth Quarter 2020 Financial Results
02/02/21 What's in Store for Innoviva (INVA) This Earnings Season?
01/27/21 Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs
01/26/21 Innoviva (INVA) Gains As Market Dips: What You Should Know

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

INVA Chatroom

User Image adampaine Posted - 1 hour ago

$INVA wow. What a great squeeze

User Image AmyJack Posted - 4 hours ago

$INVA $ETTX Somebody, please squeeze the shit out of the annoying short sellers!

User Image painebrent Posted - 6 hours ago

$INVA up 3.5 to down 3.35 AH. What the heck is going on??? The ER was great. I'm tired of this manipulation.

User Image Last10K Posted - 6 hours ago

Last10K highlighted 16 positive and negative remarks in $INVA's 10-Q filed today. See them in the Quarterly Report: https://last10k.com/sec-filings/INVA/0000950170-21-002378.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=sentiment&utm_term=inva

User Image Last10K Posted - 8 hours ago

$INVA just filed a 10-Q Quarterly Report with 48 sections and 3 exhibits. Access them all or just read their earnings: https://last10k.com/sec-filings/inva/0000950170-21-002378.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=inva

User Image ChartInsight Posted - 8 hours ago

New $INVA 10-Q fundamental charts on https://chartinsight.com/INVA-Innoviva

User Image raylin Posted - 8 hours ago

$INVA Mentioned $ETTX in our ER, hopefully it catches some eyes to help us get a reversal!

User Image AmyJack Posted - 8 hours ago

$INVA The first 3 quarters’ revenue ($284M) is close to the current estimate for annual revenue ($292M). Obviously, this stock needs more attention from WS. The market was expecting declining revenue and EPS but the company is blowing them out of the water with growing revenue. Still very high short position. We need some brokerages to push this. No ER CC, either. LOL

User Image Stonkmoon Posted - 9 hours ago

$INVA 2021-10-27 16:05 ET Innoviva Reports Third Quarter 2021 Financial Results https://stonkmoon.com/news/INVA/4eb18aef0fc869e42ea1e7186fba13f7

User Image STCKPRO Posted - 9 hours ago

$INVA NEW ARTICLE : Innoviva reports Q3 results https://www.stck.pro/news/INVA/17156801

User Image Quantisnow Posted - 9 hours ago

$INVA 📜 SEC Form 10-Q filed by Innoviva, Inc. https://quantisnow.com/insight/1923216?s=s 30 seconds delayed.

User Image Last10K Posted - 9 hours ago

$INVA just filed with the SEC a Earnings Release and a Financial Exhibit https://last10k.com/sec-filings/inva/0001104659-21-130484.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=inva

User Image AmyJack Posted - 9 hours ago

$INVA I hope they provide some insights into ETTX and equally great future quarters guidance! Wow!

User Image AmyJack Posted - 9 hours ago

$INVA Again, beat EPS by more than 100%!

User Image AmyJack Posted - 9 hours ago

$INVA Oh wait, ER! Wow!!

User Image Newsfilter Posted - 9 hours ago

$INVA Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC https://newsfilter.io/a/f7ec58904941d1c8b0a7aa85305bf06d

User Image painebrent Posted - 9 hours ago

$INVA beat expected EPS by a landslide...again!

User Image epsguid Posted - 9 hours ago

$INVA reported earnings of $0.90, consensus was $0.43 via @eWhispers #epsbeat http://eps.sh/d/inva

User Image Quantisnow Posted - 9 hours ago

$INVA 📜 Innoviva, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits https://quantisnow.com/insight/1922966?s=s 30 seconds delayed.

User Image MarketNewswire Posted - 9 hours ago

$INVA New SEC Filing: 8-K Earnings - Innoviva, Inc. (0001080014) October 27 Item 2.02. Results of Operations and Financial Condition On October 27, 2021, Innoviva, Inc. (the "Company") issued a press release regarding its results of operations and financial condition for the quarter ended September 30, 2021. A copy of the press release is furnished as Exhibit 99.1 to this Current Report. The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities (...) https://marketnewswire.live?p=158335

User Image Newsfilter Posted - 9 hours ago

$INVA Form 8-K: Results of Operations and Financial Condition On October 27, 2021, Innoviva issued a press release regarding its results of operations and financial condition for the quarter ended Sep.. https://newsfilter.io/a/3f4975fa41a1ae07e6a2300de3922a1d

User Image raylin Posted - 9 hours ago

$INVA Link to ER on their website: https://investor.inva.com/news-releases/news-release-details/innoviva-reports-third-quarter-2021-financial-results Overall 10% increase in revenue YoY.

User Image painebrent Posted - 9 hours ago

$INVA Great ER!

User Image fla Posted - 9 hours ago

$INVA [15s. delayed, acc.~90%, always check] Earnings Release October 27, 16:05:00: Q3: GAAP EPS of $0.90, Revenue $97.86M. https://s.flashalert.me/GpcVo

User Image fla Posted - 9 hours ago

$INVA [15s. delayed]: Issued Press Release on October 27, 16:05:00: Innoviva Reports Third Quarter 2021 Financial Results https://s.flashalert.me/pyJVQl

User Image cctranscripts Posted - 9 hours ago

Innoviva Reports Third Quarter 2021 Financial Results https://conferencecalltranscripts.com/summary/?id=315175&pr=true $INVA

User Image Quantisnow Posted - 9 hours ago

$INVA 📰 Innoviva Reports Third Quarter 2021 Financial Results https://quantisnow.com/insight/1922641?s=s 30 seconds delayed.

User Image Stock_Titan Posted - 9 hours ago

$INVA Innoviva Reports Third Quarter 2021 Financial Results https://www.stocktitan.net/news/INVA/innoviva-reports-third-quarter-2021-financial-d39vohz8hru6.html

User Image Newsfilter Posted - 9 hours ago

$INVA Innoviva Reports Third Quarter 2021 Financial Results https://newsfilter.io/a/e5a7f5b97fcde26912c7c5bcbb73abfd

User Image WebChronicleToday Posted - 9 hours ago

$INVA New Press Release: Innoviva Reports Third Quarter 2021 Financial Results Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” and “the Company”) today reported financial results for the third quarter ended September 30, 2021. Gross royalty revenues of $101.3 million from Glaxo Group Limited (“GSK”) for the third quarter of 2021 included royalties of $54.1 million from global net sales of RELVAR®/BREO® ELLIPTA®, royalties of $11.6 million from global net sales of ANORO® ELLIPTA® and royalties of $35.6 million from global net sales of TRELEGY® ELLIPTA®.[1] Increase in fair values of strategic equity and long term investments of $33.6 million in the third quarter of 2021 was mainly due to higher net valuation as of September 30, 2021. Income from operations increased by 12% to (...) https://webchronicletoday.com?p=184597

Analyst Ratings
Morgan Stanley Underweight Nov 11, 20
Stifel Nicolaus Hold Apr 27, 18
Deutsche Bank Hold Nov 20, 17
Morgan Stanley Underweight Oct 6, 17
Cowen & Co. Outperform Oct 31, 16
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Bickerstaff George Director Director May 25 Buy 13.21 20,000 264,200 124,560 05/25/21